FSHR and prostate cancer: Under pathological conditions, FSHR has been found in granulosa cell tumors (Chu et al. 2002), ovarian surface epithelial carcinomas (Wang et al. 2003; Bose 2008; Choi et al. 2004), ovarian Sertoli-Leydig cell tumors (Choong et al. 2002), prostate cancer (Ben-Josef et al. 1999; Mariani et al. 2006; Oduwole et al. 2021), endometrial cancer (Sheng et al. 2022), neuroendocrine tumors in the appendix (Starzynski et al. 2023), and normal fat tissue (Liu et al. 2015, 2017).